Mesenchymal stem cell transplantation in multiple sclerosis

Journal of the Neurological Sciences

Volumn 333, Issue 1-2, 2013, Pages 43-49

  Cohen, Jeffrey A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Immunomodulation; Multiple sclerosis; Neuroprotection; Regeneration; Stem cell transplantation

Indexed keywords

ALEMTUZUMAB;

ACUTE DISSEMINATED ENCEPHALOMYELITIS; ALLERGIC REACTION; ALLOTRANSPLANTATION; ARTICLE; AUTOIMMUNITY; BONE MARROW; ECTOPIC TISSUE; EXPERIMENTAL MODEL; HUMAN; INFECTION; INFLAMMATION; MALIGNANT TRANSFORMATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MULTIPLE SCLEROSIS; NEOPLASM; NONHUMAN; PERICYTE; PHASE 1 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; SAFETY;

BM; BONE MARROW; CENTRAL NERVOUS SYSTEM; CNS; EAE; EDSS; EXPANDED DISABILITY STATUS SCALE; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FBS; FETAL BOVINE SERUM; HEPATOCYTE GROWTH FACTOR; HGF; HMSC-CM; HUMAN MESENCHYMAL STEM CELL CONDITIONED MEDIUM; IBMIR; IFN; IL; IMMUNOMODULATION; INSTANT BLOOD-MEDIATED INFLAMMATORY REACTION; INTERFERON; INTERLEUKIN; INTRAVENOUS; IV; MAGNETIC RESONANCE IMAGING; MESENCHYMAL STEM CELL; MOG; MRI; MS; MSC; MULTIPLE SCLEROSIS; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; NEUROPROTECTION; REGENERATION; STEM CELL TRANSPLANTATION; TNFΑ; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MULTIPLE SCLEROSIS;

EID: 84884908632     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2012.12.009     Document Type: Article

References (126)

1. D.J. Prockop Marrow stromal cells as stem cells for nonhematopoietic tissues Science 276 1997 71 74
2. M.F. Pittenger, A.M. Mackay, S.C. Beck, R.K. Jaiswal, R. Douglas, and J.D. Mosca Multilineage potential of adult human mesenchymal stem cells Science 284 1999 143 147
3. L. Da Silva Meirelles, A.I. Caplan, and N.B. Nardi In search of the in vivo identity of mesenchymal stem cells Stem Cells 26 2008 2287 2299
4. M. Crisan, S. Yap, L. Casteilla, C.-W. Chen, M. Corselli, and T.S. Park A perivascular origin for mesenchymal stem cells in multiple human organs Cell Stem Cell 3 2008 301 313
5. M. Dominici, K. Le Blanc, I. Mueller, I. Slaper-Cortenbach, F.C. Marini, and D.S. Krause Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society For Cellular Therapy position statement Cytotherapy 8 2006 315 317
6. D. Mahad, S.M. Planchon, and J.A. Cohen Mesenchymal stem cell transplantation to treat multiple sclerosis J.A. Cohen, R.A. Rudick, Multiple sclerosis therapeutics 4th edition 2011 Cambridge University Press Cambridge 520 534
7. O. Sadan, E. Melamed, and D. Offen Bone-marrow-derived mesenchymal stem cell therapy for neurodegenerative diseases Expert Opin Biol Ther 9 2009 1487 1497
8. C. Siatskas, and C.C. Bernard Stem cell and gene therapeutic strategies for the treatment of multiple sclerosis Curr Mol Med 9 2009 992 1016
9. M.S. Freedman, A. Bar-Or, H.L. Atkins, D. Karussis, F. Frassoni, and H.M. Lazarus The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group Mult Scler 16 2010 503 510
10. D.J. Maltman, S.A. Hardy, and S.A. Przyborski Role of mesenchymal stem cells in neurogenesis and nervous system repair Neurochem Int 59 2011 347 356
11. E. Zappia, S. Casazza, E. Pedemonte, F. Benvenuto, I. Bonanni, and E. Gerdoni Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy Blood 106 2005 1755 1761
12. D.M. Karussis, N. Grigoriadis, T. Ben-Hur, B. Gouda-Kurkalli, R. Mizrachi-Kol, and O. Einstein Mesenchymal bone marrow stem cells migrate in CNS lesions in experimental autoimmune encephalomyelitis, differentiate into neuronal and glial line and downregulate EAE (abstract) Neurology 64 Suppl. 1 2005 A407
13. D. Karussis, and I. Kassis Use of stem cells for the treatment of multiple sclerosis Expert Rev Neurother 7 2007 1189 1201
14. J. Zhang, Y. Li, J. Chen, Y. Cui, M. Lu, and S.B. Elias Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice Exp Neurol 195 2005 16 26
15. E. Gerdoni, B. Gallo, S. Casazza, S. Musio, I. Bonanni, and E. Pedemonte Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis Ann Neurol 61 2007 219 227
16. K. Le Blanc, and O. Ringden Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation Biol Blood Marrow Transplant 11 2005 321 334
17. A. Uccelli, L. Moretta, and V. Pistoia Immunoregulatory function of mesenchymal stem cells Eur J Immunol 36 2006 2566 2573
18. R.E. Newman, D. Yoo, M.A. LeRoux, and A. Danilkovitch-Miagkova Treatment of inflammatory diseases with mesenchymal stem cells Inflamm Allergy Drug Targets 8 2009 110 123
19. A. Bartholomew, C. Sturgeon, M. Siatskas, K. Ferrer, K. McIntosh, and S. Patil Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo Exp Hematol 30 2002 42 48
20. K. Le Blanc, L. Tammik, B. Sundberg, S.E. Haynesworth, and O. Ringden Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatability complex Scand J Immunol 57 2003 11 20
21. P.J. Darlington, M.-N. Boivin, C. Renoux, M. Francois, J. Galipeau, and M.S. Freedman Reciprocal Th1 and Th17 regulation by mesenchymal stem cells: implications for MS Ann Neurol 68 2010 540 545
22. F. Djouad, P. Pience, C. Bony, P. Troplel, F. Apparailly, and J. Sany Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals Blood 102 2003 3837 3844
23. M. Krampera, S. Glennie, J. Dyson, D. Scott, R. Laylor, and E. Simpson Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide Blood 101 2003 3722 3729
24. S. Beyth, Z. Borovsky, D. Mevorach, M. Liebergall, Z. Gazit, and H. Aslan Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness Blood 105 2005 2214 2219
25. M. Di Nicola, C. Carlo-Stella, M. Magni, M. Milanesi, P.D. Longoni, and P. Matteucci Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli Blood 99 2002 3838 3843
26. I. Rasmusson, O. Ringden, B. Sundberg, and K. Le Blanc Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells Transplantation 76 2003 1208 1213
27. W.T. Tse, J.D. Pendleton, W.M. Beyer, M.C. Egalka, and E.C. Guinan Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation Transplantation 75 2003 389 397
28. K. Le Blanc, I. Rasmusson, C. Gotherstrom, C. Seidel, B. Sundberg, and M. Sundin Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes Scand J Immunol 60 2004 307 315
29. D. Chabannes, M. Hill, E. Merieau, J. Rossignol, R. Brion, and J.P. Soulillou A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells Blood 110 2007 3691 3694
30. A. Nasef, N. Mathieu, A. Chapel, J. Frick, S. Francois, and C. Mazurier Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G Transplantation 84 2007 231 237
31. A. Corcione, F. Benvenuto, E. Ferretti, D. Giunti, V. Cappiello, and F. Cazzanti Human mesenchymal stem cells modulate B-cell functions Blood 107 2006 367 372
32. L. Bai, D.P. Lennon, V. Eaton, K. Maier, A.I. Caplan, and S.D. Miller Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis Glia 57 2009 1192 1203
33. J. Zepp, L. Wu, and X. Li IL-17 receptor signaling and T helper 17-mediated autoimmune demyelinating disease Trends Immunol 32 2011 232 239
34. O. Einstein, N. Fainstein, I. Vaknin, R. Mizrachi-Kol, E. Reinhartz, and N. Grigoriadis Neural precursors attenuate autoimmune encephalomyelitis by peripheral immunosuppression Ann Neurol 61 2007 209 218
35. Y. Jiang, B.N. Jahagirdar, R.L. Reinhardt, R.E. Schwartz, C.D. Keene, and X.R. Ortiz-Gonzalez Pluripotency of mesenchymal stem cells derived from adult marrow Nature 418 2002 41 49
36. M.S. Rutenberg, T. Hamazaki, A.M. Singh, and N. Terada Stem cell plasticity, beyond alchemy Int J Hematol 79 2004 15 21
37. F. Rivera, S. Couillard-Despres, X. Pedre, S. Ploetz, M. Caioni, and C. Lois Mesenchymal stem cells instruct oligodrogenic fate decision on adult neural stem cells Stem Cells 24 2006 2209 2219
38. M.L. Fuller, A.K. DeChant, B. Rothstein, A. Caprariello, R. Wang, and A.K. Hall Bone morphogenetic proteins promote gliosis in demyelinating spinal cord lesions Ann Neurol 62 2007 288 300
39. L. Bai, D.P. Lennon, A.I. Caplan, A. DeChant, J. Hecker, and J. Kranso Hepatocyte growth factor mediates mesenchymal stem cell-induced recovery in multiple sclerosis models Nat Neurosci 15 2012 862 870
40. L.M. Brass Bone marrow for the brain? Exp Neurol 199 2006 16 19
41. T. Bliss, R. Guzman, M. Daadi, and G.K. Steinberg Cell transplantation therapy for stroke Stroke 38 2007 817 826
42. D.G. Phinney, and I. Isakova Plasticity and therapeutic potential of mesenchymal stem cells in the nervous system Curr Pharm Des 11 2005 1255 1265
43. D. English, S.K. Klasko, and P.R. Sanberg Elusive mechanisms of "stem-cell"-mediated repair of cerebral damage Exp Neurol 199 2006 10 15
44. D.G. Phinney, and D.J. Prockop Mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair - current views Stem Cells 25 2007 2896 2902
45. M. Chopp, Y. Li, and J. Zhang Plasticity and remodeling of brain J Neurol Sci 265 2008 97 101
46. P. Dharmasaroja Bone marrow-derived mesenchymal stem cells for the treatment of ischemic stroke J Clin Neurosci 16 2009 12 20
47. Y. Akiyama, C. Radtke, O. Honmou, and J.D. Kocsis Remyelination of the spinal cord following intravenous delivery of bone marrow cells Glia 39 2002 229 236
48. M. Dezawa, I. Takahashi, M. Esaki, M. Takano, and H. Sawada Sciatic nerve regeneration in rats induced by transplantation of in vitro differentiated bone-marrow stromal cells Eur J Neurosci 14 2001 1771 1776
49. C.-P. Zhao, C. Zhang, S.-N. Zhou, Y.-M. Xie, Y.-H. Wang, and H. Huang Human mesenchymal stromal cells ameliorate the phenotype of SOD1-G93A ALS mice Cytotherapy 9 2007 414 426
50. C. Zhang, C. Zhou, J.-J. Teng, R.-L. Zhao, and Y.-Q. Song Multiple administrations of human marrow stromal cells through cerebrospinal fluid prolong survival in a transgenic mouse model of amyotrophic lateral sclerosis Cytotherapy 11 2009 299 306
51. Y. Li, J. Chen, L. Wang, L. Zhang, M. Lu, and M. Chopp Intracerebral transplantation of bone marrow stromal cells in a 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine mouse model of Parkinson's disease Neurosci Lett 315 2001 67 70
52. O. Sadan, N. Shemesh, R. Barzilay, M. Bahat-Stromza, E. Melamed, and Y. Cohen Migration of neurotrophic factor-secreting mesenchymal stem cells toward a quinolinic acid lesion as viewed by magnetic resonance imaging Stem Cells 26 2008 2542 2551
53. A. Mahmood, D. Lu, L. Wang, Y. Li, M. Lu, and M. Chopp Treatment of traumatic brain injury in female rats with intravenous administration of bone marrow stromal cells Neurosurgery 49 2001 1196 1204
54. P. Lu, and M.H. Tuszynski Can bone marrow-derived stem cells differentiate into functional neurons? Exp Neurol 193 2005 273 278
55. M. Chopp, X.H. Zhang, Y. Li, L. Wang, J. Chen, and D. Lu Spinal cord injury in rat: treatment with bone marrow stromal cell transplantation NeuroReport 11 2000 3001 3005
56. C.P. Hofstetter, E.J. Schwarz, D. Hess, J. Widenfalk, A. El Manira, and D.J. Prockop Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery Proc Natl Acad Sci U S A 99 2002 2199 2204
57. S. Wu, Y. Suzuki, Y. Ejiri, T. Noda, H. Bai, and M. Kitada Bone marrow stromal cells enhance differentiation of cocultured neurosphere cells and promote regeneration of injured spinal cord J Neurosci Res 72 2003 343 351
58. M.M. Lalu, L. McIntyre, C. Pugliese, D. Fergusson, B.W. Winston, and J.C. Marshall Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials PLoS One 7 2012 e47559 10.1371/journal.pone.0047559
59. O.N. Koc, J. Day, M. Nieder, S.L. Gerson, H.M. Lazarus, and W. Krivit Mesenchymal stem cells. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH) Bone Marrow Transplant 30 2002 215 222
60. E.M. Horwitz, P.L. Gordon, W.K.K. Koo, J.C. Marx, M.D. Neel, and R.Y. McNall Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone Proc Natl Acad Sci U S A 99 2002 8932 8937
61. A.S. Chen-Plotkin, K.A. Vossel, M.A. Samuels, and M.H. Chen Encephalopathy, stroke and myocardial infarction with DMSO use in stem cell transplantation Neurology 68 2007 859 861
62. G. Moll, I. Rasmusson-Duprez, L. von Bahr, A.-M. Connolly-Andersen, G. Elgue, and L. Funke Are therapeutic human mesenchymal stromal cells compatible with human blood? Stem Cells 30 2012 1565 1574
63. M. Breitbach, T. Bostani, W. Roell, Y. Xia, O. Dewald, and J.N. Nygren Potential risks of bone marrow cell transplantation into infarcted hearts Blood 110 2007 1362 1369
64. I. Kassis, N. Grigoriadis, B. Gowda-Kurkalli, R. Mizrachi-Kol, T. Ben-Hur, and S. Slavin Neuoprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis Arch Neurol 65 2008 753 761
65. N. Grigoriadis, A. Lourbopoulos, R. Lagoudaki, J.-M. Frischer, E. Polyzoidou, and O. Touloumi Variable behavior and complications of autologous bone marrow mesenchymal stem cells transplanted in experimental autoimmune encephalomyelitis Exp Neurol 230 2011 78 89
66. L. von Bahr, I. Batsis, G. Moll, M. Hagg, A. Szakos, and B. Sundberg Analysis of tissues following mesenchymal stromal cell therapy in humans indicate limited long-term engraftment and no ectopic tissue formation Stem Cells 30 2012 557 564
67. O. DelaRosa, and E. Lombardo Modulation of adult mesenchymal stem cells activity by toll-like receptors: implications on therapeutic potential Mediators Inflamm 2010 2010 865601
68. R.S. Waterman, S.L. Tomchuck, S.L. Henkle, and A.M. Betancourt A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an immunosuppressive MSC2 phenotype PLoS One 5 2010 e10088
69. The CAMMS223 Trial Investigators A.J. Coles, D.A. Compston, K.W. Selmaj, S.L. Lake, and S. Moran Alemtuzumab vs. interferon beta-1a in early multiple sclerosis N Engl J Med 359 2008 1786 1801
70. The Lenercept Multiple Sclerosis Study Group The University of British Columbia MS/MRI Analysis Group. TNF neutralization in MS. Results of a randomized, placebo-controlled multicenter study Neurology 53 1999 457 465
71. N.A. Kishk, N.T. Abokrysha, and H. Gabr Possible induction of acute disseminated encephalomyelitis (ADEM)-like demyelinating illness by intrathecal mesenchymal stem cell injection J Clin Neurosci 20 2013 310 312
72. M. Moyeddin Bonab, S. Yazdanbakhsh, J. Loft, K. Alimoghaddom, F. Talebian, and F. Hooshmand Does mesenchymal stem cell therapy help multiple sclerosis patients? Iran J Immunol 4 2007 50 57
73. N. Scolding, D. Marks, and C. Rice Autologous mesenchymal bone marrow stem cells: practical considerations J Neurol Sci 265 2008 111 115
74. N.H. Riordan, T.E. Ichim, W.-P. Min, H. Wang, F. Solano, and F. Lara Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis J Transl Med 7 2009 29
75. B. Yamout, R. Hourani, H. Salti, W. Barada, T. El-Hajj, and A. Al-Katoubi Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study J Neuroimmunol 227 2010 185 189
76. D. Karussis, C. Karageorgiou, A. Vaknin-Dembinsky, B. Gowda-Kurkalli, J.M. Gomori, and I. Kassis Safety and immunologic effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis Arch Neurol 67 2010 1187 1194
77. P. Connick, M. Kolappan, C. Crawley, D.J. Webber, R. Patani, and A.W. Michell Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study Lancet Neurol 11 2012 150 156
78. F. Barkhof, M. Rocca, G. Francis, J.H.T.M. Van Waesberghe, B.M.J. Uitehaag, and O.R. Hommes Validation of diagnostic magnetic resonance imaging criteria for multiple sclerosis and response to interferon β1a Ann Neurol 53 2003 718 724
79. M. Tintore, M. Rovira, J. Rio, C. Nos, E. Grive, and J. Sastre-Garriga New diagnostic criteria for multiple sclerosis. Application in first demyelinating episode Neurology 60 2003 27 30
80. B. Neuhuber, S.A. Swanger, L. Howard, A.M. Mackay, and I. Fischer Effect of plating density and culture time on bone marrow stromal cell characteristics Exp Hematol 36 2008 1176 1185
81. H. Samuelsson, O. Ringden, H. Lonnies, and K. Le Blanc Optimizing in vitro conditions for immunomodulation and expansion of mesenchymal stromal cells Cytotherapy 11 2009 129 136
82. M. Sundin, O. Ringden, B. Sundberg, S. Nava, C. Gotherstrom, and K. Le Blanc No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients Haematologia (Budap) 92 2007 1208 1215
83. J. Wagner, T. Kean, R.G. Young, J.E. Dennis, and A.I. Caplan Optimizing mesenchymal stem cell-based theraputics Curr Opin Biotechnol 20 2009 1 6
84. Z. Lu, X. Hu, C. Jhu, D. Wang, X. Zheng, and Q. Liu Overexpression of CNTF in mesenchymal stem cells reduces demyelination and induces clinical recovery in experimental autoimmune encephalomyelitis mice J Neuroimmunol 206 2008 58 69
85. R.F. Pereira, K.W. Halford, M.D. O'Hara, D.B. Leeper, B.P. Sokolov, and M.D. Pollard Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice Proc Natl Acad Sci U S A 92 1995 4857 4861
86. R.F. Pereira, M.D. O'Hara, A.V. Laptev, K.W. Halford, M.D. Pollard, and R. Class Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta Proc Natl Acad Sci U S A 95 1998 1142 1147
87. Y. Li, H. Hisha, and M. Inaba Evidence for migration of donor bone marrow stromal cells into recipient thymus after bone marrow transplantation plus bone grafts: a role of stromal cells in positive selection Exp Hematol 28 2000 950 960
88. J. Chen, Y. Li, L. Wang, Z. Zhang, D. Lu, and M. Lu Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats Stroke 32 2001 1005 1011
89. S.M. Devine, A.M. Bartholomew, N. Mahmud, M. Nelson, S. Patil, and W. Hardy Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion Exp Hematol 29 2001 244 255
90. J. Gao, J.E. Dennis, R.F. Muzic, M. Lundberg, and A.I. Caplan The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion Cells Tissues Organs 169 2001 12 20
91. G.D. Wu, J.A. Nolta, Y.-S. Jin, M.L. Barr, H. Yu, and V.A. Starnes Migration of mesenchymal stem cells to heart allografts during chronic rejection Transplantation 75 2003 679 685
92. C. Allers, W.D. Sierralta, S. Neubauer, F. Rivera, J.J. Minguell, and P.A. Conget Dynamic of distribution of human bone marrow-derived mesenchymal stem cells after transplantation into adult unconditioned mice Transplantation 78 2004 503 508
93. P. Niemeyer, J. Vohrer, H. Schmal, P. Kasten, J. Fellenberg, and N.P. Suedkamp Survival of human mesenchymal stromal cells from bone marrow and adipose tissue after xenogenic transplantation in immunocompetent mice Cytotherapy 10 2008 784 795
94. I.B. Sokolova, N.N. Zin'kova, E.V. Shvedova, P.V. Kruglyakov, and D.G. Polyntsev Distribution of mesenchymal stem cells in the area of tissue inflammation after transplantation of the cell material via different routes Bull Exp Biol Med 143 2007 143 146
95. M. Inoue, O. Honmou, S. Oka, K. Houkin, K. Hashi, and J.D. Kocsis Comparative analysis of remyelinating potential of focal and intravenous administration of autologous bone marrow cells into the rat demyelinated spinal cord Glia 44 2003 111 118
96. A. Nakamizo, F. Marini, T. Amano, A. Khan, M. Studeny, and J. Gumoin Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas Cancer Res 65 2005 3307 3318
97. A. Chapel, J.M. Bertho, M. Bensidhoum, L. Fouillard, R.G. Young, and J. Frick Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome J Gene Med 5 2003 1028 1038
98. Y. Li, J. Chen, L. Wang, M. Lu, and M. Chopp Treatment of stroke in rat with intracarotid administration of marrow stromal cells Neurology 56 2001 1666 1672
99. P.H. Lee, J.E. Lee, H.-S. Kim, S.K. Song, H.S. Lee, and H.S. Nam A randomized trial of mesenchymal stem cells in multiple system atrophy Ann Neurol 72 2012 32 40
100. L. Danielyan, R. Schafer, A. von Ameln-Mayerhofer, M. Buadze, J. Geisler, and T. Klopfer Intranasal delivery of cells to the brain Eur J Cell Biol 88 2009 315 324
101. L. Danielyan, R. Schafer, A. von Ameln-Mayerhofer, F. Bernhard, S. Verleysdonk, and M. Buadze Therapeutic efficacy of intranasally delivered mesenchymal stem cells in a rat model of Parkinson disease Rejuvenation Res 14 2011 3 16
102. M. Mohyeddin Bonab, S. Yazdanbakhsh, J. Lotfi, K. Alimoghaddom, F. Talebian, and F. Hooshmand Does mesenchymal stem cell therapy help multiple sclerosis patients? Report of a pilot study Iran J Immunol 4 2007 50 57
103. J. Liang, H. Zhang, B. Hua, H. Wang, J. Wang, and Z.C. Han Allogeneic mesenchymal stem cells transplantation in treatment of multiple sclerosis Mult Scler 15 2009 644 646
104. C.M. Rice, E.A. Mallam, A.L. Whone, P. Walsh, D.J. Brooks, and N. Kane Safety and feasibility of autologous bone marrow cellular therapy in relapsing-progressive multiple sclerosis Clin Pharmacol Ther 87 2010 679 685
105. O.N. Koc, C. Peters, P. Auborg, S. Raghavan, S. Dyhouse, and R. DeGasperi Bone marrow-derived mesenchymal stem cells remain host-derived despite successful hematopoietic engraftment after allogeneic transplantation in patients with lysosomal and peroxisomal storage diseases Exp Hematol 27 1999 1675 1681
106. E.M. Horwitz, D.J. Prockop, L.A. Fitzpatrick, W.K.K. Koo, P.L. Gordon, and M. Neel Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta Nat Med 5 1999 309 313
107. O. Ringden, M. Uzunel, I. Rasmusson, M. Remberger, B. Sundberg, and H. Lonnies Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease Transplantation 81 2006 1390 1397
108. M. Dominici, R. Marino, V. Rasini, C. Spano, P. Paolucci, and P. Conte Donor cell-specific osteopoiesis originates from a self-renewing stem cell with a limited regenerative contribution after transplantation Blood 111 2008 4386 4391
109. K. Le Blanc, F. Frassoni, L. Ball, F. Locatelli, H. Roelofs, and I. Lewis Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study Lancet 371 2008 1579 1586
110. E. Klyushnenkova, J.D. Mosca, V. Zernetkina, M.K. Majumdar, K.J. Beggs, and D.W. Simonetti T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression J Biomed Sci 12 2005 47 57
111. I. Rasmusson, M. Uhlin, K. Le Blanc, and V. Levitsky Mesenchymal stem cells fail to trigger effector functions of cytotoxic T lymphocytes J Leukoc Biol 82 2007 887 893
112. P. Kebriaei, L. Isola, E. Bahceci, K. Holland, S. Rowley, and J. McGuirk Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease Biol Blood Marrow Transplant 15 2009 804 811
113. J.M. Hare, J.H. Traverse, T.D. Henry, N. Dib, R.K. Strumpf, and S.P. Schulman A randomized, double-blind, placebo-controlled, dose-escalation study of entravenous adult human mesenchymal stem cells (Prohymal) after acute myocardial infarction J Am Coll Cardiol 54 2009 2277 2286
114. J. Liang, H. Zhang, B. Hua, H. Wang, L. Lu, and S. Shi Allogenic mesenchymal stem cell transplantation in refractory systemic lupus erythematosus: a pilot clinical study Ann Rheum Dis 69 2010 1423 1429
115. E.M. Horwitz, D.J. Prockop, P.L. Gordon, W.K.K. Koo, L.A. Fitzpatrick, and M.D. Neel Clinical responses to bone marrow transplantation in children with severe osteogenesis perfecta Blood 97 2001 1227 1231
116. R.A. Cahill, O.Y. Jones, M. Klemperer, A. Steele, T.O. Mueller, and N. El-Badri Replacement of recipient stromal/mesenchymal cells after bone marrow transplantation using bone fragments and cultured osteoblast-like cells Biol Blood Marrow Transplant 10 2004 709 717
117. L. Zangi, R. Margalit, S. Reich-Zeliger, E. Bachar-Lustig, A. Beilhack, and R. Negrin Direct imaging of immune rejection and memory induction by allogeneic mesenchymal stromal cells Stem Cells 27 2009 2865 2874
118. A. Bacigalupo, M. Valle, M. Podesta, A. Pitto, E. Zocchi, and A. De Flora T-cell suppression mediated by mesenchymal stem cells is deficient in patients with severe aplastic anemia Exp Hematol 33 2005 819 827
119. J.M. Murphy, K. Dixon, S. Beck, D. Fabian, A. Feldman, and F. Barry Reduced chondrogenic and adipogenic activity of mesenchymal stem cells from patients with advanced osteoarthritis Arthritis Rheum 46 2002 704 713
120. N. Del Papa, N. Quirici, D. Soligo, C. Scavullo, M. Cortiana, and C. Borsotti Bone marrow endothelial progenitors are defective in systemic sclerosis Arthritis Rheum 54 2006 2605 2615
121. M.-C. Kastrinaki, P. Sidiropoulos, S. Roche, J. Ringe, S. Lehmann, and H. Kritikos Functional, molecular and proteomic characterisation of bone marrow mesenchymal stem cells in rheumatoid arthritis Ann Rheum Dis 67 2008 741 749
122. C. Bocelli-Tyndall, L. Bracci, G. Spagnoli, A. Braccini, M. Bouchenaki, and R. Ceredig Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro Rheumatology (Oxford) 46 2007 403 408
123. J. Larghero, D. Farge, A. Braccini, S. Lecourt, A. Scherberich, and E. Fois Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis Ann Rheum Dis 67 2008 443 449
124. H.A. Papadaki, M. Tsagournisakis, V. Mastorodemos, C. Pontikoglou, A. Damianaki, and K. Pyrovolaki Normal bone marrow hematopoietic stem cell reserves and normal stromal cell function support the use of autologous stem cell transplantation in patients with multiple sclerosis Bone Marrow Transplant 36 2005 1053 1063
125. E. Mallam, K. Kemp, A. Wilkins, C. Rice, and N. Scolding Characterization of in vitro expanded bone marrow-derived mesenchymal stem cells from patients with multiple sclerosis Mult Scler 16 2010 909 918
126. B. Mazzanti, A. Aldinucci, T. Biagioli, A. Barilaro, S. Urbani, and S. Dal Pozzo Differences in mesenchymal stem cell cytokine profiles between MS patients and healthy donors: implications for assessment of disease activity and treatment J Neuroimmunol 199 2008 142 150